These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37732054)

  • 1. Expression of CXCL12-CXCR4/CXCR7 chemokines in splenic fibrosis of cirrhotic spleen and its therapeutic significance.
    Lv Y; Li Y; Han X; Liu N; Zeng M
    Arch Med Sci; 2023; 19(5):1569-1575. PubMed ID: 37732054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of CXCL12-CXCR4/CXCR7 signal axis in liver regeneration and liver fibrosis].
    Cui LN; Zheng XH; Yu JH; Han Y
    Zhonghua Gan Zang Bing Za Zhi; 2021 Sep; 29(9):900-903. PubMed ID: 34638216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
    Khare T; Bissonnette M; Khare S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of CXCR4-CXCL12- and CXCR7-CXCL12-mediated immune reactions on murine P0106-125 -induced experimental autoimmune neuritis.
    Brunn A; Utermöhlen O; Mihelcic M; Sánchez-Ruiz M; Carstov M; Blau T; Ustinova I; Penfold M; Montesinos-Rongen M; Deckert M
    Neuropathol Appl Neurobiol; 2013 Dec; 39(7):772-87. PubMed ID: 23452257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma.
    Chen N; Jiang X; Wang J; Wu T; Cheng B; Xia J
    Tumour Biol; 2016 Jan; 37(1):567-75. PubMed ID: 26232325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
    Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
    J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR.
    Circelli L; Sciammarella C; Guadagno E; Tafuto S; del Basso de Caro M; Botti G; Pezzullo L; Aria M; Ramundo V; Tatangelo F; Losito NS; Ieranò C; D'Alterio C; Izzo F; Ciliberto G; Colao A; Faggiano A; Scala S
    Oncotarget; 2016 Apr; 7(14):18865-75. PubMed ID: 26934559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma.
    McConnell AT; Ellis R; Pathy B; Plummer R; Lovat PE; O'Boyle G
    Br J Dermatol; 2016 Dec; 175(6):1210-1220. PubMed ID: 27167239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells.
    Zabel BA; Lewén S; Berahovich RD; Jaén JC; Schall TJ
    Mol Cancer; 2011 Jun; 10():73. PubMed ID: 21672222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of chemokine CXCL12 and its receptor (CXCR4 and CXCR7) in different molecular subtypes of human breast carcinoma and the clinical significance].
    Wu W; Qian L; Dai J; Ding B; Chen X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Feb; 42(2):147-153. PubMed ID: 28255115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the new CXCL12 receptor, CXCR7, in gliomas.
    Calatozzolo C; Canazza A; Pollo B; Di Pierro E; Ciusani E; Maderna E; Salce E; Sponza V; Frigerio S; Di Meco F; Schinelli S; Salmaggi A
    Cancer Biol Ther; 2011 Jan; 11(2):242-53. PubMed ID: 21084856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR7 agonists inhibit the function of CXCL12 by down-regulation of CXCR4.
    Uto-Konomi A; McKibben B; Wirtz J; Sato Y; Takano A; Nanki T; Suzuki S
    Biochem Biophys Res Commun; 2013 Feb; 431(4):772-6. PubMed ID: 23333329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer.
    Zheng N; Liu W; Chen J; Li B; Liu J; Wang J; Gao Y; Shao J; Jia L
    Mol Carcinog; 2019 Jan; 58(1):144-155. PubMed ID: 30259564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXC chemokine receptor 7 (CXCR7) regulates CXCR4 protein expression and capillary tuft development in mouse kidney.
    Haege S; Einer C; Thiele S; Mueller W; Nietzsche S; Lupp A; Mackay F; Schulz S; Stumm R
    PLoS One; 2012; 7(8):e42814. PubMed ID: 22880115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients.
    D'Alterio C; Spina A; Arenare L; Chiodini P; Napolitano M; Galdiero F; Portella L; Simeon V; Signoriello S; Raspagliesi F; Lorusso D; Pisano C; Colombo N; Zannoni GF; Losito NS; De Cecio R; Scognamiglio G; Califano D; Russo D; Tuninetti V; Piccirillo MC; Gargiulo P; Perrone F; Pignata S; Scala S
    Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells.
    Boudot A; Kerdivel G; Habauzit D; Eeckhoute J; Le Dily F; Flouriot G; Samson M; Pakdel F
    PLoS One; 2011; 6(6):e20898. PubMed ID: 21695171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not.
    Neve Polimeno M; Ierano C; D'Alterio C; Simona Losito N; Napolitano M; Portella L; Scognamiglio G; Tatangelo F; Maria Trotta A; Curley S; Costantini S; Liuzzi R; Izzo F; Scala S
    Cell Mol Immunol; 2015 Jul; 12(4):474-82. PubMed ID: 25363530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma.
    Liberman J; Sartelet H; Flahaut M; Mühlethaler-Mottet A; Coulon A; Nyalendo C; Vassal G; Joseph JM; Gross N
    PLoS One; 2012; 7(8):e43665. PubMed ID: 22916293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.